Abstract
This article examines the general principles of psychopharmacologic treatment of obsessive-compulsive disorder (OCD) in children and adolescents. It includes a description of the currently approved medications for the treatment of children and adolescents with OCD, their side effect profiles, approaches to refractory OCD, and a discussion of drug interactions. Future directions for research are also considered.
Original language | English (US) |
---|---|
Pages (from-to) | 617-634 |
Number of pages | 18 |
Journal | Child and Adolescent Psychiatric Clinics of North America |
Volume | 8 |
Issue number | 3 |
DOIs | |
State | Published - 1999 |
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Psychiatry and Mental health